AirBuFo Forspiro 160/4,5 mikrograma po dozi, prašak inhalata, dozirani
| Name | AirBuFo Forspiro 160/4,5 mikrograma po dozi, prašak inhalata, dozirani |
|---|---|
| Marketing Authorisation Number | HR-H-824195818 |
| Active Substance | budezonid formoterolfumarat dihidrat |
| Composition | jedna isporučena doza (inhalacijska doza) sadrži 160 mikrograma budezonida i 4,5 mikrograma formoterolfumarat dihidrata |
| Pharmaceutical Form | prašak inhalata, dozirani |
| Manufacturer | Aeropharm GmbH, Rudolstadt, Njemačka Lek Pharmaceuticals d.d., Ljubljana, Slovenija Salutas Pharma GmbH, Barleben, Njemačka |
| Marketing Authorisation Holder | Sandoz d.o.o., Maksimirska 120, Zagreb, Hrvatska |
| Marketing Authorisation Date | 27.02.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/22-02/107 |
| Registration Number | 381-12-01/171-23-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | ponovljivi recept |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | R03AK07 |
| Marketing status | stavljeno u promet |
| Shortage status | nema nestašice |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
